Among the growth factors, the altered expression of TGFB2 and TGFB3 was also associated with other top canonical pathways as “Apelin cardiac fibroblast signaling pathway” (p < 6.59 × 10−4) and “FAT10 Cancer Signaling Pathway” (p < 1.29 × 10−3) (Figure 4 and Table S4), in addition to “Cardiac hypertrophy signaling (enhanced)”. This evidence concerns the gene TGFB2 and cancer.